Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
about
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationSensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.Risk factors for coronary disease: the time for a paradigm shift?Role of the gut in modulating lipoprotein metabolism.Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity.Very-low-density lipoprotein: complex particles in cardiac energy metabolism.Pathophysiological mechanisms of carotid plaque vulnerability: impact on ischemic stroke.Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages.Early alterations in the postprandial VLDL1 apoB-100 and apoB-48 metabolism in men with strong heredity for type 2 diabetes.Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitus.Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes.Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference.Lipoprotein composition in children and adolescents with type 1 diabetes mellitus.Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans.
P2860
Q26864770-017DF5A3-2DDB-4E07-985B-8FF3427AA16EQ33402916-A155A763-53ED-43EE-862F-637A0C2C9450Q33887783-E71FB01A-D422-4A3A-8665-BE4DCEC213DCQ34471608-CC4660EE-D5A6-4AB1-AA21-6B9AAFD5F9FEQ35192357-58B665BE-64A5-4E2A-BEA8-7E652B4F804EQ37377090-E39B1876-DE31-4069-9E37-D750188DDB86Q37902919-58F0FD80-953C-463C-94F5-FD96EFAF0AA2Q38040358-456491FB-CB95-45A0-ACF9-03B9FED3EBEAQ40137109-A70FE2B9-ED07-4D8B-B82E-9C678E825A15Q40535355-6E268B0B-D699-421F-9555-0BAA7C4A8C51Q44355809-9B56FFFF-EB99-41E6-984A-338714E8B4B9Q46015949-0A440C35-B655-49F5-AD18-2BC5EE3A9B77Q46379405-28893558-F8F6-4F38-AD0C-2032616A5D66Q46424760-DB5FB340-D47D-43B2-94FC-A9D3EF30B6C3Q51384216-004E69EA-662E-44C7-AB60-918149254F85
P2860
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@ast
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@en
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@nl
type
label
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@ast
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@en
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@nl
prefLabel
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@ast
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@en
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@nl
P2860
P356
P1476
Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis.
@en
P2093
P2860
P356
10.1002/DMRR.179
P577
2001-01-01T00:00:00Z